ANOMALY WEALTHMutual Fund Intelligence HoldingsSep 2026 Trade Intelligence ↗
FUNCTION CODESType a code in the search bar and press Enter
TOPWhat funds are buyingBUYMost bought stocks (₹)SELLMost sold stocks (₹)SCRNStock screenerSECTSectorsINSOwnership & liquidity insightsFLOWMoney flowsHEATFlow heatmapNFONew fund offersSIPSIP trendsFIIFII & DII dailyCATCategoriesFUNDFund explorerCMPCompare fundsAMCFund housesSHRFund-house market shareXRAYPortfolio X-rayMONMonthly reportDIGWhat changedRESResearch: what held upDATAData status
KEYBOARDAnywhere outside a text box

/Command bar

?This help

ghHome

gmMonthly report

gaWhat funds are buying

gsStocks

gfFunds

glMoney flows

gcCategories

goFund houses

gxPortfolio X-ray

grResearch

Economic portfolio

LIC MF HEALTHCARE FUND

LIC LIC Mutual Fund Jul 2023 — Sep 2026 36 months

Data periodFund holdingsSep 2026NSE prices23 Oct 2026Data status →

Indian listed equity disclosed₹96.90 CrAt NSE closes, Sep 2026
Companies held2525 with an NSE price
Top 10 holdings61.7%Of the equity shown here
Largest holding9.8%Sun Pharmaceutical Industries Limited
12-month turnover40.0%Estimated from 9 monthly disclosures · compare

Days to sell half: 0.2 — selling half of every holding at 20% of each stock’s usual daily NSE trading, the time to get through 90% of the portfolio (Sep 2026). Quick to unwind on normal volumes. Small-cap comparison →

Shares of this fund’s disclosed Indian listed equity, valued at official NSE closing prices. Cash, debt, derivatives and overseas holdings are not included, so for a hybrid or debt fund these are shares of its equity part only. Not performance, and not a recommendation.

How concentrated it has been

36 priced months, Jul 2023 to Sep 2026 · at each month’s NSE closes

Top 10 holdings, share of equity

61.7% now, 53.6% in Sep 2025 · highest 82.0%, lowest 51.1%

Companies held

25 now, 29 in Sep 2025 · largest single holding 9.8% of equity

How long new positions last: of the 19 companies this fund started holding between Aug 2023 and Jul 2025, 74% were still held a year later — it usually keeps what it buys. Across active funds the figure is about 50%, and a fund’s figure has stayed similar from year to year. A description of how the fund is run, not of its results. How this was tested →

How it trades: no clear lean toward recent winners or losers (score -0.10 over 10 months; −1 always buys the biggest fallers, +1 the biggest risers, 0 no pattern). Value and contra funds average −0.10, other active funds about 0. A description of behaviour, not of results. How this was tested →

Funds most like this one

Overlap of disclosed equity · the smaller share of each company both hold, added up

  1. Mirae Asset Nifty 500 Healthcare ETFMirae Asset · 20 shared58.2%
  2. EODWHFEdelweiss · 15 shared58.0%
  3. Mirae Asset Healthcare FundMirae Asset · 14 shared57.7%
  4. Axis NIFTY Healthcare ETFAxis · 13 shared56.3%
  5. ICICI Prudential Nifty Healthcare ETFICICI Prudential · 13 shared56.3%
  6. DSP Nifty Healthcare Index FundDSP · 13 shared56.3%
  7. DSP Nifty Healthcare ETFDSP · 13 shared56.3%
  8. ADITYA BIRLA SUN LIFE NIFTY HEALTHCARE ETFAditya Birla Sun Life · 13 shared56.3%

Select one to see exactly what the two funds share. Index funds and ETFs tracking the same index overlap almost completely.

What changed in Sep 2026

This portfolio’s consecutive disclosures · evidenced adjustments applied

New positions 2 Companies added
Complete exits 0 Companies sold out
Increases 4 More shares than last month
Reductions 9 Fewer shares than last month

Share quantities, not market values or cash flows.

Holdings by value

Sep 2026 · largest 100 · share of the equity shown

Download all (CSV)
CompanySectorSizeShare of equityValueShares heldHeld since
Sun Pharmaceutical Industries Limited Healthcare Large Cap 9.83% 9.53 Cr 52,436 by Jul 2023 (36 mo+)
Divi's Laboratories Limited Healthcare Large Cap 9.30% 9.01 Cr 9,700 by Jul 2023 (36 mo+)
Neuland Laboratories Limited Healthcare Small Cap 6.30% 6.10 Cr 2,859 Aug 2024 (23 mo)
Torrent Pharmaceuticals Limited Healthcare Large Cap 6.19% 6.00 Cr 12,500 by Jul 2023 (36 mo+)
Apollo Hospitals Enterprise Limited Healthcare Large Cap 5.90% 5.72 Cr 7,000 by Jul 2023 (36 mo+)
Aurobindo Pharma Limited Healthcare Mid Cap 5.36% 5.19 Cr 31,050 Jan 2025 (19 mo)
Navin Fluorine International Limited Chemicals Small Cap 5.11% 4.95 Cr 6,000 Aug 2024 (23 mo)
Zydus Lifesciences Limited Healthcare Mid Cap 5.10% 4.94 Cr 42,500 May 2026 (5 mo)
Aster DM Quality Care Limited Healthcare Small Cap 4.73% 4.58 Cr 65,750 May 2026 (5 mo)
Fortis Healthcare Limited Healthcare Mid Cap 3.86% 3.74 Cr 48,600 Apr 2025 (16 mo)
Metropolis Healthcare Limited Healthcare Small Cap 3.44% 3.33 Cr 61,500 Aug 2023 (35 mo)
Gland Pharma Limited Healthcare Small Cap 3.28% 3.18 Cr 10,977 Jul 2025 (13 mo)
Mankind Pharma Limited Healthcare Mid Cap 3.19% 3.09 Cr 12,327 Feb 2024 (29 mo)
Nephrocare Health Services Limited Healthcare Small Cap 3.13% 3.03 Cr 46,000 Sep 2026 (1 mo)
Max Healthcare Institute Limited Healthcare Large Cap 3.07% 2.98 Cr 32,000 Apr 2025 (16 mo)
Cohance Lifesciences Limited Healthcare Small Cap 3.02% 2.93 Cr 65,950 Jul 2026 (3 mo)
Glenmark Pharmaceuticals Limited Healthcare Mid Cap 2.67% 2.59 Cr 11,100 Mar 2024 (28 mo)
Global Health Limited Healthcare Mid Cap 2.66% 2.58 Cr 18,879 Aug 2023 (35 mo)
Dr. Agarwal's Health Care Limited Not classified Small Cap 2.52% 2.44 Cr 51,001 Jan 2025 (19 mo)
Biocon Limited Healthcare Mid Cap 2.43% 2.35 Cr 63,500 May 2026 (5 mo)
IPCA Laboratories Limited Healthcare Mid Cap 2.39% 2.31 Cr 12,000 by Jul 2023 (36 mo+)
Onesource Specialty Pharma Limited Healthcare Small Cap 2.36% 2.28 Cr 15,009 Feb 2025 (18 mo)
Piramal Pharma Limited Healthcare Small Cap 1.47% 1.42 Cr 69,000 Sep 2026 (1 mo)
Syngene International Limited Healthcare Small Cap 1.41% 1.37 Cr 37,400 Aug 2026 (2 mo)
Artemis Medicare Services Limited Not classified Small Cap 1.29% 1.25 Cr 36,215 Sep 2023 (34 mo)

Half of its current holdings have been held for 19 disclosed months or more without a break. “By” means held in the first month we have for this fund, so possibly for longer. Counted over this fund’s own monthly disclosures; a merger (e.g. HDFC into HDFC Bank, July 2023) starts a new run for the surviving company.

Recent position changes

Latest 100 company-month records · evidenced adjustments applied

CompanyMonthActivityAdjusted change
Piramal Pharma Limited Sep 2026 ▲ New position +69,000
Artemis Medicare Services Limited Sep 2026 ▼ Reducing -57,314
Nephrocare Health Services Limited Sep 2026 ▲ New position +46,000
Syngene International Limited Sep 2026 ▲ Increasing +12,400
Max Healthcare Institute Limited Sep 2026 ▲ Increasing +6,725
Fortis Healthcare Limited Sep 2026 ▲ Increasing +5,568
Metropolis Healthcare Limited Sep 2026 ▲ Increasing +5,371
IPCA Laboratories Limited Sep 2026 ▼ Reducing -4,604
Global Health Limited Sep 2026 ▼ Reducing -3,373
Gland Pharma Limited Sep 2026 ▼ Reducing -3,066
Glenmark Pharmaceuticals Limited Sep 2026 ▼ Reducing -894
Navin Fluorine International Limited Sep 2026 ▼ Reducing -716
Torrent Pharmaceuticals Limited Sep 2026 ▼ Reducing -630
Divi's Laboratories Limited Sep 2026 ▼ Reducing -418
Apollo Hospitals Enterprise Limited Sep 2026 ▼ Reducing -217
Syngene International Limited Aug 2026 ▲ New position +25,000
Cohance Lifesciences Limited Aug 2026 ▲ Increasing +11,450
Dr. Agarwal's Health Care Limited Aug 2026 ▲ Increasing +11,425
Aster DM Quality Care Limited Aug 2026 ▲ Increasing +10,250
Metropolis Healthcare Limited Aug 2026 ▲ Increasing +8,825
Divi's Laboratories Limited Aug 2026 ▼ Reducing -1,365
Cohance Lifesciences Limited Jul 2026 ▲ New position +54,500
Anthem Biosciences Limited Jul 2026 ▼ Complete exit -25,333
Aster DM Quality Care Limited Jul 2026 ▲ Increasing +18,000
Max Healthcare Institute Limited Jul 2026 ▲ Increasing +8,500
Acutaas Chemicals Limited Jul 2026 ▼ Complete exit -6,296
Mankind Pharma Limited Jul 2026 ▲ Increasing +3,750
Divi's Laboratories Limited Jul 2026 ▲ Increasing +1,400
Zydus Lifesciences Limited Jun 2026 ▲ Increasing +16,500
Piramal Pharma Limited May 2026 ▼ Complete exit -0.02 Cr
Biocon Limited May 2026 ▲ New position +63,500
Aster DM Quality Care Limited May 2026 ▲ New position +37,500
Zydus Lifesciences Limited May 2026 ▲ New position +26,000
Concord Biotech Limited May 2026 ▼ Complete exit -20,531
Cipla Limited May 2026 ▼ Complete exit -19,567
Vinati Organics Limited May 2026 ▼ Complete exit -8,741
Global Health Limited May 2026 ▲ Increasing +7,300
Onesource Specialty Pharma Limited May 2026 ▼ Reducing -7,150
Alkem Laboratories Limited May 2026 ▼ Complete exit -5,008
Divi's Laboratories Limited May 2026 ▲ Increasing +3,925
Navin Fluorine International Limited May 2026 ▲ Increasing +2,600
Abbott India Limited May 2026 ▼ Complete exit -968
Neuland Laboratories Limited May 2026 ▲ Increasing +274
Aurobindo Pharma Limited May 2026 ▼ Reducing -251
Cipla Limited Jan 2026 ▼ Reducing -11,651
Piramal Pharma Limited Jan 2026 ▲ Increasing +10,010
Acutaas Chemicals Limited Jan 2026 ▼ Reducing -2,006
Fortis Healthcare Limited Jan 2026 ▲ Increasing +930
Onesource Specialty Pharma Limited Jan 2026 ▲ Increasing +833
Neuland Laboratories Limited Jan 2026 ▲ Increasing +117
Piramal Pharma Limited Dec 2025 ▲ Increasing +9,966
Concord Biotech Limited Dec 2025 ▲ Increasing +2,787
Linde India Limited Dec 2025 ▼ Complete exit -1,559
Sun Pharmaceutical Industries Limited Dec 2025 ▼ Reducing -1,415
Navin Fluorine International Limited Dec 2025 ▼ Reducing -680
Alkem Laboratories Limited Dec 2025 ▼ Reducing -147
Onesource Specialty Pharma Limited Dec 2025 ▲ Increasing +123
Neuland Laboratories Limited Dec 2025 ▲ Increasing +54
Artemis Medicare Services Limited Nov 2025 ▼ Reducing -15,303
Concord Biotech Limited Nov 2025 ▲ Increasing +4,346
IPCA Laboratories Limited Nov 2025 ▼ Reducing -1,707
Acutaas Chemicals Limited Nov 2025 ▼ Reducing -1,409
Alkem Laboratories Limited Nov 2025 ▼ Reducing -1,057
Onesource Specialty Pharma Limited Nov 2025 ▲ Increasing +743
Dr. Agarwal's Health Care Limited Oct 2025 ▼ Reducing -10,108
J.B. Chemicals & Pharmaceuticals Lt Oct 2025 ▼ Complete exit -9,736
Onesource Specialty Pharma Limited Oct 2025 ▲ Increasing +4,885
Anthem Biosciences Limited Oct 2025 ▲ Increasing +4,466
Gland Pharma Limited Jul 2025 ▲ New position +13,351
Anthem Biosciences Limited Jul 2025 ▲ New position +12,536
Syngene International Limited Jul 2025 ▼ Reducing -11,112
Dr. Agarwal's Health Care Limited Jul 2025 ▼ Reducing -10,625
Vinati Organics Limited Jul 2025 ▼ Reducing -6,663
J.B. Chemicals & Pharmaceuticals Lt Jul 2025 ▼ Reducing -5,016
Apollo Hospitals Enterprise Limited Jul 2025 ▲ Increasing +2,459
Zydus Lifesciences Limited Jul 2025 ▼ Reducing -2,182
Neuland Laboratories Limited Jul 2025 ▼ Reducing -597
Linde India Limited Jul 2025 ▼ Reducing -199
Glenmark Pharmaceuticals Limited Jul 2025 ▼ Reducing -156
Acutaas Chemicals Limited Jun 2025 ▲ New position +9,711
Fortis Healthcare Limited Jun 2025 ▼ Reducing -5,612
Navin Fluorine International Limited Jun 2025 ▼ Reducing -1,840
Sanofi Consumer Healthcare India Limited Jun 2025 ▼ Complete exit -1,740
Piramal Pharma Limited May 2025 ▼ Reducing -38,176
Artemis Medicare Services Limited May 2025 ▼ Reducing -28,276
Laurus Labs Limited May 2025 ▼ Complete exit -25,578
Fortis Healthcare Limited May 2025 ▲ Increasing +21,555
Sun Pharmaceutical Industries Limited May 2025 ▲ Increasing +7,513
Onesource Specialty Pharma Limited May 2025 ▼ Reducing -6,964
Cipla Limited May 2025 ▲ Increasing +3,947
Linde India Limited May 2025 ▲ New position +1,758
Global Health Limited May 2025 ▼ Reducing -1,742
Mankind Pharma Limited May 2025 ▼ Reducing -1,729
Neuland Laboratories Limited May 2025 ▲ Increasing +827
Sanofi Consumer Healthcare India Limited May 2025 ▲ Increasing +45
Fortis Healthcare Limited Apr 2025 ▲ New position +26,159
Max Healthcare Institute Limited Apr 2025 ▲ New position +16,775
Artemis Medicare Services Limited Apr 2025 ▼ Reducing -16,688
Glenmark Pharmaceuticals Limited Apr 2025 ▼ Reducing -12,464
Zydus Lifesciences Limited Apr 2025 ▼ Reducing -10,902

Changes compare consecutive month-end disclosures for this portfolio only.